Editas Medicine Reports Preclinical Data Demonstrating
Preclinical data demonstrating Editas-engineered AsCas12a multiplexed editing of iPSCs enhances iNK tumor killing ability, supporting promise as a...
United Kingdom United States Marks Shearman Exposition Of The American Society Hematology Editas Medicine Inc Editas Engineered Ascas
Source: globenewswire.com